Safety and efficacy of combination treatment with calcineurin inhibitors and vedolizumab in patients with refractory inflammatory bowel disease

Clinical Gastroenterology and Hepatology

from Gastroenterology via xlomafota13 on Inoreader https://ift.tt/2k0GmEz
via IFTTT